Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Olanzapine ODT 10 mg vs originator in healthy Thai volunteers under fasting
TCTR20190323001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of olanzapine (2 arms), sponsored by Bio-innova. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
olanzapine
Beyond the preview
Go deeper on TCTR20190323001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190323001.